Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers

Breast Care ◽  
2022 ◽  
Author(s):  
Marcus Jannes ◽  
Alexander König ◽  
Martin Kolben ◽  
Claudius Fridrich ◽  
Verena Kirn

Introduction: The risk for metastasis at primary diagnosis of breast cancer is about 4%. The German guidelines give clear indications for when, whom and how to stage breast cancer patients. Ideally, this should be done via CAT scan of the thorax and abdomen and an additional bone scan. But daily practice shows that the way health care providers handle staging recommendations can vary. To objectify adherence to guidelines we started a nation-wide survey. Methods: Between July and September 2020 we sent out a survey via email to all certified and non certified breast centers and in addition to all Departments of Obstetrics and Gynecology in Germany. We asked for timing of staging, conditions that cause staging and the applied method. In case we did not get back any reply we sent out a reminder. Results: A total of 220 certified breast centers/28 non-certified breast center/48 Departments of Gynecology and Obstetrics who care for breast cancer patients took part in our survey. A general pre-therapeutic staging was performed in 16,4%/39,3%/66,7% of all institutions and a general post-operative staging was performed in 4,1%/0%/6,3% of each institutional type, respectively. In terms of the applied method, 75% of all certified breast centers used a CAT scan and bone scan, while 23,3% primarily use chest x-ray, ultrasound of the abdomen (27,7%) or MRI. As a potential reason for using x-ray and ultrasound the presence of a „low-risk“ breast cancer was mentioned. Summary: Although certified breast centers show the highest adherence to current guidelines, some still perform a general staging or do not use the recommended staging method. The low probability for primary metastatic breast cancer and the use of a reasonable exposure to radiation warrant a critical discussion.

2020 ◽  
Author(s):  
Ramaiah Vinay Kumar

Abstract Background: Automatic Cone-beam computed tomography (CBCT) based image matching for set-up verification is recommended as compared to 2-D match for post-operative local / loco-regional radiotherapy of breast cancer patients by Volumetric Modulated Arc Therapy (VMAT) technique. However, in supine position, off-midline peripheral body Clinical Target Volume (CTV) of unilateral breast cancer patients immobilized on Breast and Lung board of All-in-One (AIO) positioning systemmay necessitate augmented movement of couch in ‘x’ and ‘z’ axis thereby raising the risk of collusion of x-ray sources / detectors system with couch. Methods and Materials: VMAT was planned by a pair of partial arc for whole target volume for seven consecutive post-operative breast cancer patients (five post-mastectomy and two post-breast conservation patients). Tattoo based set-up by shift of treatment table in x-, y- and z-axis as determined by Treatment Planning System followed by X-rays with planar image acquisition and online 2-D imaging matching was performed for set-up verification. In-room 360°rotation of x-ray source and detector system of linear accelerator (linac) was performed before x-ray planar image acquisition. Results: Completion of 360°rotation in-room of x-ray source and detector system of linacaround the machine iso-centre was not possible in six out of seven patients due to possibility of collusion of gantry with contralateral side of the couch. Conclusion: Performing CBCT for generating 3D images for computed tomography (CT) reconstruction may not be practical for patient set-up verification of post-operative radiotherapy of unilateral breast cancer patients positioned supine on breast and lung board.


2016 ◽  
Vol 37 (12) ◽  
pp. 1318-1324
Author(s):  
Minjung Seo ◽  
Byung Kyun Ko ◽  
Soon Young Tae ◽  
Su-Jin Koh ◽  
Young Ju Noh ◽  
...  

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e11122-e11122
Author(s):  
D. Landau ◽  
S. M. Constantino ◽  
S. Maddipatla ◽  
Z. J. Zhang ◽  
M. Hart ◽  
...  

Onkologie ◽  
2011 ◽  
Vol 34 (7) ◽  
pp. 362-367 ◽  
Author(s):  
Matthias W. Beckmann ◽  
Cosima Brucker ◽  
Volker Hanf ◽  
Claudia Rauh ◽  
Mayada R. Bani ◽  
...  

2009 ◽  
Vol 30 (9) ◽  
pp. 736-741 ◽  
Author(s):  
Dae Sik Kim ◽  
Sung Hwan Hong ◽  
Ja-Young Choi ◽  
Jin Chul Paeng ◽  
Na Ra Kim ◽  
...  

2015 ◽  
Vol 05 (03) ◽  
pp. 149-158
Author(s):  
Yukinori Okada ◽  
Tatsuyuki Abe ◽  
Yasuo Nakajima ◽  
Itsuko Okuda ◽  
Brandon D. Lohman ◽  
...  

2001 ◽  
Vol 12 (5) ◽  
pp. 724-725 ◽  
Author(s):  
G. Curigliano ◽  
G. Ferretti ◽  
M. Colleoni ◽  
E. Marrocco ◽  
G. Peruzzotti ◽  
...  

Author(s):  
Brittany Speller ◽  
Kelly Metcalfe ◽  
Erin D. Kennedy ◽  
Marcia Facey ◽  
Ellen Greenblatt ◽  
...  

Abstract Background Premenopausal breast cancer patients are at risk of treatment-related infertility. Many patients do not receive sufficient fertility information before treatment. As such, our team developed and alpha tested the Begin Exploring Fertility Options, Risks, and Expectations decision aid (BEFORE DA). Methods The BEFORE DA development process was guided by the International Patient Decision Aids Standards and the Ottawa Decision Support Framework. Our team used integrated knowledge translation by collaborating with multiple stakeholders throughout the development process including breast cancer survivors, multi-disciplinary health care providers (HCPs), advocates, and cancer organization representatives. Based on previously conducted literature reviews and a needs assessment by our team – we developed a paper prototype. The paper prototype was finalized at an engagement meeting with stakeholders and created into a graphically designed paper and mirrored online decision aid. Alpha testing was conducted with new and previously engaged stakeholders through a questionnaire, telephone interviews, or focus group. Iterative reviews followed each step in the development process to ensure a wide range of stakeholder input. Results Our team developed an 18-page paper prototype containing information deemed valuable by stakeholders for fertility decision-making. The engagement meeting brought together 28 stakeholders to finalize the prototype. Alpha testing of the paper and online BEFORE DA occurred with 17 participants. Participants found the BEFORE DA usable, acceptable, and most provided enthusiastic support for its use with premenopausal breast cancer patients facing a fertility decision. Participants also identified areas for improvement including clarifying content/messages and modifying the design/photos. The final BEFORE DA is a 32-page paper and mirrored online decision aid (https://fertilityaid.rethinkbreastcancer.com). The BEFORE DA includes information on fertility, fertility options before/after treatment, values clarification, question list, next steps, glossary and reference list, and tailored information on the cost of fertility preservation and additional resources by geographic location. Conclusion The BEFORE DA, designed in collaboration with stakeholders, is a new tool for premenopausal breast cancer patients and HCPs to assist with fertility discussions and decision-making. The BEFORE DA helps to fill the information gap as it is a tool that HCPs can refer patients to for supplementary information surrounding fertility.


Sign in / Sign up

Export Citation Format

Share Document